Form D · Biotechnology
CERENIS THERAPEUTICS HOLDING S.A.
Labege, I0 · CIK 0001637994
Offering snapshot reported Mar 31, 2015 · SEC filing
- Reported sold
- $4.12M Offering amount: $4.12M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2015 | Initial | $4,119,251 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-237034
Source: Form D, filed Mar 31, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christian Chavy | Director |
| Jean Louis Dasseux | Director, Executive |
| Michael Harvey Davidson | Director |
| N/A Healthcap Iv Bis | Director |
| Olivier Martinez | Director |
| Richard Pasternak | Director |
| Marc Riviere | Director |
| N/A Sofinnova Partners | Director |
| Cyrille Tupin | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
265 Rue De La Decouverte
Labege, I0, 31670
Labege, I0, 31670